The Prime Minister of Australia responded to Trump's tariffs: there will be no equal countermeasures, and negotiations for exemptions will be sought.
① Australian Prime Minister Albanese criticized USA President Trump for imposing a 10% tariff on allies, stating that such actions are not what friends do, and indicated that Australia will not impose equivalent tariffs on the USA; ② The Australian government will seek to negotiate with the USA in hopes that Trump will lift the tariffs on Australia.
Imugene Receives Cohort Review Committee Clearance for Phase One Trial Dose Escalation
Imugene Clears First IV Dose Level in Phase 1 OnCARlytics Trial for Solid Tumours | ASX:IMU, OTC:IUGNF
Express News | Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
Why Clover, DroneShield, Imugene, and New Hope Shares Are Racing Higher Today
ASX Midday Sector Update: Healthcare, Energy Stocks Soar, Utilities Struggle
Imugene Obtains US FDA Fast Track Designation for Azer-cel Lymphoma Treatment; Shares Up 6%
Guess Which ASX Stock Is Surging 11% on Big US FDA News
Imugene Limited Reports Progress in Cancer Therapies
Why Are ASX 200 Tech Stocks Getting Slammed on Tuesday?
Imugene Ltd: Half Yearly Report and Accounts
Why GQG, Imugene, Mirvac, and Temple & Webster Shares Are Pushing Higher
Imugene Therapy Achieves Two Complete Responses in Patients With Blood Cancer, Shares Rise Past 8%
Which ASX 200 Healthcare Share Will Pay the Best Dividend Yield in 2025?
Imugene Receives A$11.7 Million R&D Tax Refund
Imugene Receives A$11.7 Million R&D Tax Refund | ASX:IMU, OTC:IUGNF
Imugene Ltd: Imugene Receives $11.7m R&D Tax Refund
Why Cettire, Gold Road, Imugene, and Paladin Energy Shares Are Racing Higher
First Aussie Doses Bring Imugene Major Step Closer to 'Quicker, Cheaper' Non-Hodgkin's Lymphoma Care
Guess Which ASX Small Cap Stock Is Jumping on 'Significant Milestone'